Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond E Meyn

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Molecular Cancer Therapeutics|August 10, 2004
Inhibition of constitutively activated nuclear factor-kappaB radiosensitizes human melanoma cellsAnupama Munshi, John F Kurland, Takashi Nishikawa, et al.
International Journal of Radiation Oncology, Biology, Physics|October 3, 2006
Effect of downregulation of survivin expression on radiosensitivity of human epidermoid carcinoma cellsNand K Sah, Anupama Munshi, Marvette Hobbs, et al.
Oncogene|July 27, 2004
Adenoviral-mediated mda-7 expression suppresses DNA repair capacity and radiosensitizes non-small-cell lung cancer cellsTakashi Nishikawa, Anupama Munshi, Michael D Story, et al.
Molecular Cancer Therapeutics|August 25, 2006
Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX fociAnupama Munshi, Toshimitsu Tanaka, Marvette L Hobbs, et al.
Oncotarget|June 28, 2014
Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cellsKathleen A Bridges, Carlo Toniatti, Carolyn A Buser, et al.
The Journal of Biological Chemistry|March 29, 2003
Translation inhibitors sensitize prostate cancer cells to apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by activating c-Jun N-terminal kinaseNand K Sah, Anupama Munshi, John F Kurland, et al.
Neoplasia (New York, N.Y.)|April 14, 2006
Targeted apoptosis activation with GrB/scFvMEL modulates melanoma growth, metastatic spread, chemosensitivity, and radiosensitivityYuying Liu, Weihe Zhang, Ting Niu, et al.
Oncogene|December 3, 2003
A comprehensive assessment of p53-responsive genes following adenoviral-p53 gene transfer in Bcl-2-expressing prostate cancer cellsKevin B Spurgers, Kevin R Coombes, Raymond E Meyn, et al.
Oncotarget|October 1, 2016
MK-8776, a novel chk1 kinase inhibitor, radiosensitizes p53-defective human tumor cellsKathleen A Bridges, Xingxing Chen, Huifeng Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activityAnupama Munshi, John F Kurland, Takashi Nishikawa, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Molecular Cancer Therapeutics|August 10, 2004
Inhibition of constitutively activated nuclear factor-kappaB radiosensitizes human melanoma cellsAnupama Munshi, John F Kurland, Takashi Nishikawa, et al.
International Journal of Radiation Oncology, Biology, Physics|October 3, 2006
Effect of downregulation of survivin expression on radiosensitivity of human epidermoid carcinoma cellsNand K Sah, Anupama Munshi, Marvette Hobbs, et al.
Oncogene|July 27, 2004
Adenoviral-mediated mda-7 expression suppresses DNA repair capacity and radiosensitizes non-small-cell lung cancer cellsTakashi Nishikawa, Anupama Munshi, Michael D Story, et al.
Molecular Cancer Therapeutics|August 25, 2006
Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX fociAnupama Munshi, Toshimitsu Tanaka, Marvette L Hobbs, et al.
Oncotarget|June 28, 2014
Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cellsKathleen A Bridges, Carlo Toniatti, Carolyn A Buser, et al.
The Journal of Biological Chemistry|March 29, 2003
Translation inhibitors sensitize prostate cancer cells to apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by activating c-Jun N-terminal kinaseNand K Sah, Anupama Munshi, John F Kurland, et al.
Neoplasia (New York, N.Y.)|April 14, 2006
Targeted apoptosis activation with GrB/scFvMEL modulates melanoma growth, metastatic spread, chemosensitivity, and radiosensitivityYuying Liu, Weihe Zhang, Ting Niu, et al.
Oncogene|December 3, 2003
A comprehensive assessment of p53-responsive genes following adenoviral-p53 gene transfer in Bcl-2-expressing prostate cancer cellsKevin B Spurgers, Kevin R Coombes, Raymond E Meyn, et al.
Oncotarget|October 1, 2016
MK-8776, a novel chk1 kinase inhibitor, radiosensitizes p53-defective human tumor cellsKathleen A Bridges, Xingxing Chen, Huifeng Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activityAnupama Munshi, John F Kurland, Takashi Nishikawa, et al.
Pageof 5